2C-T-30
2C-T-30, also known as 4--2,5-dimethoxyphenethylamine or as 2C-T-FB, is a serotonin receptor modulator of the phenethylamine and 2C families. It is the derivative of 2C-T in which the 4-methylthio group has been replaced with a 4- group. According to Daniel Trachsel, 2C-T-30 was not clearly active at a dose of 6mg plus 3mg orally and its duration and effects are unknown. However, it was said that it might have helped increase ability to concentrate on tasks. The drug is a potent partial agonist of the serotonin 5-HT2A receptor and also interacts with other serotonin receptors and targets. The chemical synthesis of 2C-T-30 has been described. 2C-T-30 was first described in the scientific literature by Trachsel in 2003. It is a controlled substance in Canada under phenethylamine blanket-ban language.